ETEPLIRSEN

CHEBI:CHEBI_749902

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

generic_name
ETEPLIRSEN
rxcui
1810582
brand_name
Exondys 51
brand_name_base
Exondys 51
pharm_class
Antisense [CS]
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT
listing_expiration_date
20241231
dosage_form
INJECTION
route
INTRAVENOUS
active_ingredient_strength
100 mg/2mL
marketing_start_date
20160919
labeler_name
Sarepta Therapeutics, Inc.
package_marketing_start_date
19-SEP-16
manufacturer_name
Sarepta Therapeutics, Inc.
nui
M0025055
pharm_class_epc
Antisense Oligonucleotide [EPC]
pharm_class_cs
Oligonucleotides, Antisense [CS]
active_ingredient_name
ETEPLIRSEN
product_ndc
61434-035
spl_id
ddf619ee-8a76-40dc-91fb-50f82aca74f3
package_ndc
61434-035-01
package_description
288 VIAL in 1 CASE (61434-035-01) / 10 mL in 1 VIAL
application_number
NDA206488
unii
AIW6036FAS
spl_set_id
33bff678-7829-479e-9110-b8e33a0bc0aa
upc
0360923363027
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class